Research and Administrative Support Services - U.S. Naval Medical Research Unit South
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The U.S. Naval Medical Research Unit South (NAMRU SOUTH), under the Department of the Navy, has issued a Request for Information (RFI) for Research and Administrative Support Services. This RFI, identified as A030551, seeks non-personal / non-severable research and development support. The primary locations for performance are Lima, Peru; Iquitos, Peru; and Soto Cano Air Force Base, Honduras, with potential for other sites within the U.S. Southern Command (SOUTHCOM) area of responsibility. Responses are due by 5:00 P.M. ET on May 26, 2026.
Scope of Work
This RFI is for services under NAICS Code 541715 (Research and Development in the Physical, Engineering, and Life Sciences) and PSC AN42 (Health R&D Services; Applied Research). The contractor will provide managerial, administrative, and direct labor personnel, materials, and transportation to support NAMRU SOUTH's mission of ensuring the operational readiness and health of U.S. Service members and Peruvian partners through health sciences research and infectious disease surveillance.
Key research areas include, but are not limited to:
- Vaccine trials, drug studies, and technology evaluation.
- Epidemiologic studies and bio-surveillance of infectious diseases, including vectors.
- Development and evaluation of devices and therapeutic countermeasures for diseases such as malaria, bacterial diarrhea, emerging viral pathogens (e.g., dengue, chikungunya, Zika), influenza, leishmaniasis, and multi-drug resistant bacteria.
- Data collection and support for regulated studies, adhering to FDA regulatory standards, Good Clinical Practices (GCP), and the International Conference on Harmonization (ICH).
The draft Performance Work Statement (PWS) further details support for Bacteriology, Entomology, Parasitology, Virology, Research Administration, Clinical Trials, and Veterinary Services departments.
Contract & Timeline
- Type: Request for Information (RFI) / Sources Sought
- Set-Aside: None specified (This is market research, not a solicitation)
- Response Due: May 26, 2026, 5:00 P.M. ET
- Published: May 11, 2026
Requirements & Response Instructions
Respondents MUST have a current Federal Wide Assurance (FWA) issued by the Department of Health and Human Services (DHHS). Responses must include:
- A cover letter with company name, point of contact, phone, email, DUNS, and CAGE Code.
- A capabilities statement demonstrating a clear understanding and ability to perform the entire scope and all tasks described in the PWS.
- Confirmation of a current/active FWA and its expiration date.
- Confirmation that the company is deemed "responsible" per FAR 9.104-1.
- Confirmation of current/active SAM.gov registration.
Note: Contractors able to perform only a portion of the work will not be considered. This is strictly an RFI; no proposals or offers will be considered, and no contract will be awarded from this announcement. All responses should be emailed to Dakota Laughlin at dakota.w.laughlin.civ@us.navy.mil.
Additional Notes
The PWS outlines special requirements for personnel (work permits, security clearances, health assessments), research compliance (FWA, HRPO, IACUC, GCP, ICH), IT access, Organizational Conflict of Interest (OCI) mitigation plans, and language proficiency (Spanish/English) for various labor categories.